SCHEMBL7665355

SCHEMBL7665355

CCOC(=O)c1cn(-c2ccnc(SC)n2)c(-c2cccc(C(F)(F)F)c2)n1

nearest known ligand 0.48

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GABRA2 P47869 9/20 0.48
GABRB2 P47870 9/20 0.48
MLYCD O95822 1/20 0.47
MEN1 O00255 1/20 0.45
MAPT P10636 1/20 0.45
KMT2A Q03164 1/20 0.45
KDM4E B2RXH2 3/20 0.45
ALDH1A1 P00352 1/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44
GRIN1 Q05586 1/20 0.40
GRIN2B Q13224 1/20 0.40
BRAF P15056 1/20 0.40
CYP1A2 P05177 1/20 0.40
CYP2C9 P11712 1/20 0.40
CYP2C19 P33261 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
MAPK9 P45984 1/20 0.40
SYK P43405 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7566543 0.85 GABRA2 (0.48) GABRA2GABRB2MLYCDMEN1MAPT
SCHEMBL7534386 0.85 GABRA2 (0.48) GABRA2GABRB2MLYCDMEN1MAPT
SCHEMBL7664658 0.81 MAPK9 (0.61) GABRA2GABRB2MLYCDMEN1MAPT
SCHEMBL7665202 0.80 MAPK14 (0.51) GABRA2GABRB2MAPK9
SCHEMBL7661360 0.80 GABRA2 (0.45) GABRA2GABRB2MLYCDMEN1MAPT
SCHEMBL7665192 0.80 MAPK14 (0.51) GABRA2GABRB2MAPK9
SCHEMBL7665100 0.78 GABRA2 (0.45) GABRA2GABRB2MLYCDMEN1MAPT
SCHEMBL20384716 0.71 KDM4E (0.54) GABRA2GABRB2MEN1MAPTKMT2A
SCHEMBL10958938 0.69 FAAH (0.54) MEN1MAPTKMT2AKDM4EALDH1A1
SCHEMBL30504042 0.69 FAAH (0.54) MEN1MAPTKMT2AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6492516-B1 PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF WHICH EXHIBIT UTILITY FOR THE TREATMENT OF CYTOKINE MEDIATED DISEASES SUCH AS ARTHRITIS. MERCK & CO., INC. 2002-12-10 US disclosed